TP53 and neoplasm: Instead, the lack of p53 overexpression in the K5/6-only group, consistent with the “urothelial-like B” or “basal/squamous-like” subtypes, implies a distinct regulatory pathway of tumor progression in the K5/6-only group, which warrants further investigation [4].